Medical Licensing (MD/DO) · Independent exam preparation
European Board Examination in Neurological Surgery: Free Preparation Guide Study Guide
Practise neurosurgical localisation, emergency decisions, tumour assessment and CSF management with 60 focused concepts, 20 explained questions and 20 recall cards.
By CertMedbry · Updated 19 October 2026
Practise localising neurological deficits, recognising surgical emergencies, interpreting investigations and balancing treatment benefit against neurological harm. This selective guide supports Part I knowledge preparation and the clinical reasoning needed for Part II across adult and paediatric neurosurgery. Its 60 concepts cover every published subject domain, with greater emphasis on neuroanatomy and neuro-oncology. The official examination outline defines the full scope, including topics beyond this selection. The identified issuer documents are undated; their published allocations are not confirmed as the effective October 2026 blueprint.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and qualification does this guide address?
It addresses the European Board Examination in Neurological Surgery, administered through EBNS, the board formed jointly by EANS and the UEMS Section of Neurosurgery. The workbook name “European Board of Neurosurgery Examination” refers to this examination. The earlier Diploma Examination in Neurosurgery became a board examination following the October 2015 agreement; candidates passing both parts from 2016 onwards receive FEBNS.
Fellow of the European Board of Neurological Surgery — Examination and Scope · EANS Annual Report 2024–2025
Is FEBNS a national medical licence or a substitute for national specialist certification?
FEBNS is a postgraduate neurosurgical fellowship assessment, with a standard appropriate to independent specialist practice. The issuer explicitly states that it does not replace a national examination where one exists. National competent authorities retain responsibility for specialist training and national recognition; fellowship alone does not establish a national licence to practise.
Fellow of the European Board of Neurological Surgery — Examination and Scope · UEMS European examinations
What question count, duration and item styles are documented for Part I?
The identified documents describe 100 single-best-answer questions, each with five options, completed in 2 hours 20 minutes, with no negative marking. Items include short factual questions and clinical scenarios. The documents do not identify a separate scored/pretest split, establish adaptive delivery or confirm the delivery platform. These details describe the published documents, rather than a verified October 2026 examination specification.
Fellowship of the European Board of Neurological Surgeons: Part 1 Exam · Fellow of the European Board of Neurological Surgery — Examination and Scope
How is Part II structured?
The scope document describes three 30-minute oral assessments: brain, spine, and combined brain/spine. Each assessment is marked independently by two examiners. The examination is conducted in English, and successful completion of Part I is required before Part II. Equal assessment durations do not establish equal scoring weights. The supplied documents do not establish a numerical passing score.
Fellow of the European Board of Neurological Surgery — Examination and Scope
Which published subject allocations guide this selection?
The undated Part I allocation assigns 15 questions each to Neuroanatomy and Neuro-oncology; 10 each to Neurophysiology/ pharmacology, Trauma and Critical Care, Neuroradiology, Neurovascular, Spine, and Hydrocephalus/ CSF disorders/ Congenital; and two each to Neurology, Infection, Functional/ epilepsy, Peripheral nerve, and Miscellaneous including statistics and ethics. These total 100. Neither issuer outline states a revision identifier or effective date, and filename numbers are not effective dates. This guide approximates that distribution while ensuring coverage of every domain; the small question and card sets necessarily give smaller domains proportionally more representation.
Fellowship of the European Board of Neurological Surgeons: Part 1 Exam · Fellow of the European Board of Neurological Surgery — Examination and Scope
How are paediatric neurosurgery and the broader syllabus represented?
The published Part I document requires at least five paediatric questions within the full 100-question examination, distributed across subject areas. The broader scope covers Basic Science and Cranial and Spinal Neurosurgery, emphasising urgent and emergency care. This selective guide includes neonatal hydrocephalus, congenital obstruction and paediatric epilepsy decisions. The official outline remains the full scope; additional study is needed in areas such as spinal trauma, biomechanics, movement-disorder surgery, pain procedures and the wider range of congenital disorders.
Fellowship of the European Board of Neurological Surgeons: Part 1 Exam · Fellow of the European Board of Neurological Surgery — Examination and Scope
Why do some older descriptions mention 150 questions?
An older handbook describes 150 questions across two papers. That historical format is not the outline adopted here. The identified later scope and allocation documents describe 100 questions, but their effective dates are unstated. Candidates should use the issuer’s instructions for their booked sitting to resolve any subsequent changes.
Fellow of the European Board of Neurological Surgery — Older Handbook · Fellowship of the European Board of Neurological Surgeons: Part 1 Exam
Do the practice questions reproduce the examination or predict a pass?
These are 20 original, independent four-option single-best-answer learning drills with explanations, including two explicitly paediatric cases. The published Part I document specifies five options. The drills support knowledge and reasoning practice; they do not reproduce secure examination items, simulate the oral assessments or predict a passing result.
Fellowship of the European Board of Neurological Surgeons: Part 1 Exam · Fellow of the European Board of Neurological Surgery — Examination and Scope
Independently authored learning materials for a postgraduate neurosurgical assessment at the standard of independent specialist practice. The European Board of Neurological Surgery is EBNS; passing both examination parts leads to FEBNS fellowship.
Outline used: Limited to the official undated published examination scope in 211221_Fellow_of_the_Europea.pdf and Part I allocation in 210713_Exam_part_I_-_info_an.pdf. Neither document states a revision identifier or effective date. This guide does not claim alignment with an effective October 2026 blueprint or present the published allocations as confirmed current examination weights. The filename tokens are not treated as effective dates. The workbook label “European Board of Neurosurgery Examination” maps to the official examination name “European Board Examination in Neurological Surgery”; the assigned slug is preserved. This mapping does not denote a separate current exam.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Neuroanatomy15% in the identified undated published Part I allocation; not a confirmed October 2026 weight
1.How does bitemporal field loss localise a lesion?
Nasal retinal fibres cross in the optic chiasm and carry information from the temporal visual fields. A lesion affecting the central chiasm therefore produces temporal field loss in both eyes, often respecting the vertical meridian. This pattern differs from monocular loss caused by a prechiasmatic lesion and homonymous loss caused by a retrochiasmatic lesion. Formal fields establish the distribution more reliably than a patient’s description of blurred vision.
Apply it
An adult with a sellar mass reports bumping into objects on either side. Perimetry shows bilateral temporal defects. Relate the deficit to crossing nasal retinal fibres and examine the relationship between the mass and optic chiasm.
Common pitfall: Calling the defect bilateral optic nerve disease overlooks its organised temporal distribution. Chiasmal compression need not initially produce a complete, symmetrical bitemporal hemianopia.
2.Which visual fibres are endangered during temporal surgery?
Meyer’s loop carries inferior retinal fibres through the temporal lobe around the anterior temporal horn. Because retinal images are inverted, these fibres represent the contralateral superior visual field. Injury can therefore cause a contralateral superior quadrantanopia. Parietal optic radiations carry superior retinal information representing the inferior field. Distinguish retinal location from visual-field location when predicting operative deficits, and recognise that individual anatomy limits prediction from surface landmarks alone.
Apply it
After left temporal surgery, a patient misses objects in the upper right field of both eyes. Localise the deficit to left temporal optic radiations and document formal fields before advising about activities requiring intact peripheral vision.
Common pitfall: Inferior retinal fibres represent superior visual space. Reversing that relationship produces the wrong quadrant even when the correct cerebral hemisphere has been identified.
3.How does the pyramidal crossing determine weakness laterality?
Most corticospinal fibres cross in the caudal medulla before descending in the lateral corticospinal tract. A cerebral hemisphere or upper brainstem lesion therefore usually causes contralateral limb weakness, whereas a spinal cord lesion causes ipsilateral upper motor neuron weakness below the lesion. Segmental anterior horn or root injury can add lower motor neuron findings at the affected level. Combining laterality with reflexes and the sensory examination distinguishes these anatomical possibilities.
Apply it
A patient develops right leg spasticity and right-sided loss of joint position below a thoracic sensory level. The shared laterality of these findings supports a right spinal cord lesion rather than a left cerebral motor lesion.
Common pitfall: The rule that brain lesions cause contralateral weakness cannot be applied unchanged below the pyramidal decussation. Acute cord injury may also initially lack spasticity.
4.Why does posterior-column injury cause ipsilateral sensory loss?
Posterior-column fibres carrying vibration and conscious proprioception ascend ipsilaterally in the spinal cord. They synapse in the gracile or cuneate nuclei before crossing as internal arcuate fibres in the medulla and forming the medial lemniscus. A unilateral spinal lesion therefore impairs these modalities on the same side below the lesion. Impaired position sense can cause sensory ataxia, particularly when visual compensation is removed during examination.
Apply it
A patient can stand with eyes open but becomes markedly unstable when closing them. Reduced vibration and toe-position sense in the right leg direct attention to proprioceptive pathways, with laterality interpreted according to the suspected lesion level.
Common pitfall: Instability alone does not establish cerebellar disease. Dependence on visual compensation and impaired joint-position testing favour sensory ataxia, although mixed lesions can occur.
5.How does a central cord cavity produce dissociated sensory loss?
Pain and temperature pathways cross near their spinal entry levels through the anterior white commissure before ascending in the contralateral anterolateral system. A central cord cavity can interrupt these crossing fibres while initially sparing posterior columns. The result can be bilateral segmental pain and temperature loss with preserved vibration and position sense. A cervical cavity may produce a cape-like distribution and can also affect nearby anterior horn cells.
Apply it
A young adult has painless burns across the shoulders, preserved finger-position sense and intrinsic hand wasting. The combination suggests a cervical central cord process affecting crossing sensory fibres and segmental motor neurons; spinal imaging should test that localisation.
Common pitfall: A preserved vibration examination does not exclude spinal cord disease. Dissociation between sensory modalities can be the strongest clue to a central cord lesion.
6.Why can a small internal-capsule lesion cause dense weakness?
Descending motor pathways converge into a compact arrangement within the internal capsule before continuing into the cerebral peduncle. A small lesion can consequently affect a large proportion of motor output and cause substantial contralateral weakness. Cortical lesions may produce a more restricted motor distribution or accompanying cortical signs, depending on their extent. The relationship between lesion volume and deficit severity therefore depends strongly on the concentration of fibres at the affected site.
Apply it
An adult has sudden dense right-sided weakness without aphasia or neglect. Imaging identifies a small left capsular lesion. Explain the severe deficit through compact motor-fibre organisation rather than assuming the lesion is too small to be clinically important.
Common pitfall: Absence of cortical signs supports a subcortical localisation but does not prove a specific vascular mechanism. Imaging and the full examination remain necessary.
7.How do crossed cranial nerve and limb findings localise the brainstem?
Brainstem lesions can injure an ipsilateral cranial nerve nucleus or fascicle together with long pathways serving the opposite side of the body. This produces crossed findings, such as an ipsilateral cranial nerve palsy with contralateral limb weakness. The affected cranial nerve helps identify the rostrocaudal level, while accompanying sensory, cerebellar and autonomic signs refine the localisation. A single hemispheric lesion generally does not explain this combination as economically.
Apply it
A patient has left tongue weakness with deviation on protrusion and right limb weakness. Consider a left medullary lesion involving hypoglossal motor structures and corticospinal fibres above their crossing, then examine vibration and position sense for further localisation.
Common pitfall: Do not assign every cranial nerve abnormality to a peripheral nerve lesion. A simultaneous contralateral long-tract deficit strongly redirects localisation toward the brainstem.
8.Which structures make the foramen of Monro an important operative landmark?
The foramen of Monro connects each lateral ventricle to the third ventricle. Its close relationship to the fornix makes orientation important during intraventricular surgery because the fornix participates in memory circuitry. Obstruction at this junction can enlarge an upstream lateral ventricle without requiring obstruction of the aqueduct. Ventricular size patterns and the position of intraventricular lesions should therefore be interpreted using the sequence of normal CSF connections.
Apply it
Imaging shows marked enlargement of one lateral ventricle and a lesion at its junction with the third ventricle. Localise the obstruction to the corresponding foramen of Monro and identify adjacent memory-related structures when discussing the operative corridor.
Common pitfall: Treating all ventriculomegaly as a uniform communicating process misses focal obstruction. Ventricular asymmetry can identify the blocked connection and alter procedural planning.
9.Which vessels lie beneath the third ventricular floor during ventriculostomy?
The basilar artery complex lies in close relation to the third ventricular floor, making vascular anatomy central to endoscopic third ventriculostomy. The intended opening passes through the floor into the underlying cisternal CSF space, but a high or closely apposed basilar artery can narrow the safe working relationship. Recognising the mammillary bodies, infundibular region and underlying vascular position is more informative than assuming a constant distance between these structures.
Apply it
Before ventriculostomy in a patient with obstructive hydrocephalus, sagittal imaging shows the basilar apex closely applied to the third ventricular floor. Incorporate that relationship into procedural feasibility and avoid assuming that a conventional surface landmark guarantees vascular clearance.
Common pitfall: A thin or translucent ventricular floor is not evidence that the underlying space is free of vessels. Individual vascular relationships determine the immediate hazard.
Neurosurgical anatomy of the floor of the third ventricle and related vascular structures
Neurophysiology/ pharmacology10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
10.How should cerebral perfusion pressure be calculated and interpreted?
Cerebral perfusion pressure is commonly estimated as mean arterial pressure minus intracranial pressure when ICP is the relevant downstream pressure. Both systemic hypotension and intracranial hypertension can therefore reduce perfusion. The Brain Trauma Foundation fourth edition recommends a CPP target range of 60–70 mm Hg in severe TBI, with individual requirements influenced by autoregulation. A calculated CPP must be interpreted alongside clinical findings and correctly referenced pressure measurements.
Apply it
An adult with severe TBI has MAP 86 mm Hg and ICP 24 mm Hg, giving CPP 62 mm Hg. If sedation lowers MAP to 72 without changing ICP, CPP falls to 48 despite unchanged intracranial pressure.
Common pitfall: A satisfactory systemic blood pressure does not establish adequate cerebral perfusion when ICP is high. Conversely, lowering ICP while allowing MAP to collapse can worsen CPP.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition · Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
11.Why can small intracranial volume increases cause abrupt deterioration?
The skull limits expansion, so an added mass initially requires compensatory displacement of CSF and venous blood. Once compensation is exhausted, a further small volume increase can produce a disproportionate ICP rise. This explains why a previously stable patient can deteriorate rapidly as a lesion enlarges. Pressure trends, neurological examination and CT evidence of compressed CSF spaces together reveal risk more effectively than a single apparently modest lesion measurement.
Apply it
A patient with an expanding traumatic lesion becomes drowsy after an initially stable interval. Repeat CT shows worsening cisternal compression. Interpret the deterioration as possible exhaustion of intracranial compensation, requiring immediate reassessment rather than reassurance from the earlier examination.
Common pitfall: Clinical stability at one time point does not establish continuing intracranial reserve. A small additional volume can have major consequences once compensatory capacity is depleted.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
12.Why can hyperventilation lower ICP while threatening cerebral oxygen delivery?
Lowering arterial carbon dioxide causes cerebral vasoconstriction, reducing cerebral blood volume and potentially ICP. The same response can reduce cerebral blood flow and worsen ischaemia in vulnerable tissue. The Brain Trauma Foundation advises against prolonged prophylactic hyperventilation to PaCO2 of 25 mm Hg or less. Its discussion distinguishes this practice from short-term temporising use during acute deterioration, when definitive treatment and assessment of oxygen delivery remain essential.
Apply it
A ventilated adult with severe TBI has controlled ICP and no herniation signs. A proposed sustained PaCO2 target of 23 mm Hg would expose the patient to cerebral vasoconstriction without an established indication for this degree of prophylactic hyperventilation.
Common pitfall: A falling ICP after increasing ventilation is not proof of improved brain perfusion. Pressure reduction and oxygen delivery can move in opposite directions.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
13.When are high-dose barbiturates considered for intracranial hypertension?
High-dose barbiturates can suppress cerebral metabolic activity and help control ICP that remains elevated despite maximum standard medical and surgical treatment. Their haemodynamic effects can undermine cerebral perfusion, so stability before and during treatment is essential. The Brain Trauma Foundation distinguishes this rescue indication from prophylactic induction of EEG burst suppression, which is not recommended. Treatment selection therefore depends on refractory intracranial hypertension rather than coma severity alone.
Apply it
An adult has persistent intracranial hypertension after appropriate lesion treatment and standard ICU measures. Before considering barbiturate therapy, assess whether systemic circulation can support cerebral perfusion and establish monitoring for both haemodynamic effects and the intended cerebral response.
Common pitfall: Burst suppression is a physiological treatment endpoint, not a reason to expose every severe TBI patient to barbiturates. Prophylaxis and rescue treatment have different indications.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
14.How should propofol-related ICP improvement be interpreted?
Propofol can be used to control ICP, but improvement in that physiological measure does not establish improved survival or long-term neurological outcome. The Brain Trauma Foundation specifically separates ICP control from mortality and six-month outcome benefit and cautions about morbidity with high doses. Sedation decisions should therefore account for blood pressure, cerebral perfusion and treatment adverse effects, rather than escalating treatment solely to obtain an attractive ICP trace.
Apply it
After propofol escalation, ICP decreases from 25 to 18 mm Hg but MAP falls substantially. Recalculate CPP and reassess the sedation strategy; the lower ICP alone cannot demonstrate that the net cerebral haemodynamic effect is beneficial.
Common pitfall: A useful effect on a surrogate endpoint does not guarantee patient-centred benefit. Escalation can become counterproductive when systemic adverse effects offset intracranial improvement.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
15.What distinguishes early seizure prophylaxis from prevention of post-traumatic epilepsy?
Early post-traumatic seizures occur within seven days of injury. The Brain Trauma Foundation fourth edition supports phenytoin to reduce early seizures when benefits outweigh complications, but does not recommend prophylactic phenytoin or valproate to prevent late seizures. Its evidence review did not establish levetiracetam superiority over phenytoin for early prophylaxis. Preventing an early provoked seizure and preventing later epilepsy are therefore different therapeutic claims requiring different evidence.
Apply it
A family asks whether short-term antiseizure prophylaxis after severe TBI guarantees that epilepsy will never develop. Explain that the immediate aim is reducing early post-traumatic seizures; it does not establish prevention of the later epileptic disorder.
Common pitfall: Do not convert a short-term prophylactic indication into indefinite treatment without a separate clinical reason. An actual seizure also changes the question from prophylaxis to management.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
Trauma and Critical Care10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
16.When does an acute subdural haematoma meet operative criteria?
The Brain Trauma Foundation surgical guideline recommends evacuation of acute SDH exceeding 10 mm thickness or 5 mm midline shift, irrespective of GCS. A smaller lesion can still require surgery in a comatose patient with neurological deterioration, abnormal pupils or elevated ICP. These are complementary clinical and radiological criteria. Once an operative indication exists, evacuation should proceed as soon as possible rather than waiting for consciousness to worsen.
Apply it
An adult remains conversational after head injury, but CT shows a 12 mm acute SDH with 4 mm shift. The thickness criterion independently supports urgent evacuation; the relatively preserved GCS does not remove the operative indication.
Common pitfall: Both radiological thresholds need not be exceeded. Requiring simultaneous excessive thickness and shift incorrectly delays treatment when either established criterion is already present.
17.Which epidural haematomas can be observed?
An epidural haematoma larger than 30 cm3 warrants surgical evacuation regardless of GCS in the Brain Trauma Foundation surgical guideline. Observation is reserved for patients meeting the combined lower-risk features: volume below 30 cm3, thickness below 15 mm, shift below 5 mm, GCS above 8 and no focal deficit. Such management requires close neurological observation and serial CT in a neurosurgical centre, rather than assuming a small haematoma is harmless.
Apply it
An alert adult has a 20 cm3 epidural haematoma measuring 10 mm thick, with 2 mm shift and no focal deficit. These findings permit consideration of monitored nonoperative care, provided serial imaging and immediate neurosurgical response are available.
Common pitfall: Low volume alone is insufficient for observation. A focal deficit, greater mass effect or declining consciousness changes the risk assessment even when volume remains below the threshold.
18.When does a traumatic contusion require operative treatment?
Traumatic parenchymal lesions require assessment of neurological trajectory, mass effect and ICP control. The Brain Trauma Foundation recommends operative treatment for lesion-related deterioration, medically refractory intracranial hypertension or significant mass effect. It also identifies specified volume and imaging criteria, including frontal or temporal contusions above 20 cm3 in patients with GCS 6–8 when accompanied by at least 5 mm shift or cisternal compression. Stable lesions without these features can be monitored.
Apply it
A patient with GCS 7 has a 26 cm3 temporal contusion and compressed basal cisterns. This combination supports operative assessment, even if the lesion appears less striking than an extra-axial haematoma on the same CT series.
Common pitfall: A contusion is not automatically managed conservatively because it lies within brain tissue. Progressive deterioration and mass effect can create a clear operative indication.
19.Why are posterior fossa traumatic masses especially time-critical?
Posterior fossa masses can compress the brainstem and obstruct the fourth ventricle within a restricted compartment. The Brain Trauma Foundation identifies fourth ventricular distortion or obliteration, cisternal compression and obstructive hydrocephalus as evidence of important mass effect. Neurological dysfunction or deterioration attributable to the lesion also supports surgery. When operative criteria are present, evacuation should occur promptly because clinical decline can be rapid and the initial examination may underestimate evolving danger.
Apply it
Following trauma, an adult becomes progressively drowsy. CT shows a posterior fossa haematoma compressing the fourth ventricle with upstream ventricular enlargement. Treat the combination as an urgent mass-lesion problem rather than an isolated ventricular-size abnormality.
Common pitfall: Supratentorial size thresholds cannot simply be transferred to the posterior fossa. Location and obstruction can make a comparatively small lesion clinically dangerous.
20.Why are corticosteroids inappropriate for severe traumatic brain injury?
Corticosteroids should not be used to improve outcome or reduce ICP in severe TBI. The Brain Trauma Foundation identifies increased mortality with high-dose methylprednisolone and considers that treatment contraindicated. This recommendation is disease-specific: the presence of cerebral oedema does not mean that treatments used for tumour-associated vasogenic oedema are beneficial after trauma. Establishing the cause of swelling is therefore essential before transferring a familiar treatment between conditions.
Apply it
An adult with severe TBI has diffuse swelling and no tumour or other steroid indication. A proposal for high-dose methylprednisolone should be rejected on TBI outcome evidence, while established intracranial hypertension measures and lesion reassessment continue.
Common pitfall: The word oedema does not identify a common treatment across all brain diseases. A plausible anti-inflammatory rationale cannot outweigh demonstrated harm in severe TBI.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
21.How should an elevated ICP value influence treatment?
The Brain Trauma Foundation fourth edition recommends treating ICP above 22 mm Hg because higher values are associated with increased mortality. Management nevertheless integrates the pressure trend, neurological examination and CT findings. A brief artefact and sustained intracranial hypertension do not carry identical meaning. Elevated ICP should trigger assessment of measurement validity, cerebral perfusion and treatable causes, including an evolving mass lesion, rather than automatic escalation through drugs without diagnostic reassessment.
Apply it
A monitored adult has repeated ICP values of 27–30 mm Hg with worsening pupillary asymmetry. Confirm the signal while urgently reassessing for a structural cause; the associated neurological change makes isolated numerical treatment inadequate.
Common pitfall: A threshold supports action but does not specify the cause or optimal intervention. Conversely, an apparently acceptable ICP does not override new focal deterioration.
Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
Neuroradiology10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
22.How strongly does restricted diffusion support a brain abscess?
Restricted diffusion within the centre of a ring-enhancing lesion supports abscess because purulent material can limit water movement. It is a useful discriminator from many necrotic tumours, but it is not pathognomonic. The supplied original study documents overlap, including restricted diffusion in a metastasis. Imaging must therefore be integrated with infection history, immune status, lesion morphology and appropriate tissue or microbiological assessment when a definitive diagnosis will change treatment.
Apply it
An adult with a ring-enhancing lesion has central diffusion restriction but also a known systemic malignancy. Keep abscess prominent while retaining tumour in the differential; the diffusion finding alone cannot safely determine the complete treatment pathway.
Common pitfall: Replacing “supports abscess” with “proves abscess” converts a useful imaging sign into an unjustified certainty. Necrotic neoplasms can occasionally share the finding.
Restricted diffusion within ring enhancement is not pathognomonic for brain abscess
23.Why must diffusion-weighted images be checked against ADC maps?
High signal on diffusion-weighted imaging can reflect restricted diffusion or persistent T2-related signal. A corresponding low apparent diffusion coefficient supports genuinely reduced water mobility. DWI brightness without low ADC should therefore not automatically be described as restriction. This distinction matters when interpreting ring-enhancing lesions because diagnostic arguments based on restriction require the diffusion measurement itself, rather than the visual brightness of one sequence in isolation.
Apply it
A ring-enhancing lesion appears bright on DWI, but its centre has high ADC. Reconsider the claim of central restriction before using that feature to favour pus over necrotic tumour, and review the complete MRI sequence set.
Common pitfall: DWI is not an independent binary abscess test. Failing to inspect ADC can confuse T2 shine-through with restricted diffusion and distort the differential diagnosis.
Restricted diffusion within ring enhancement is not pathognomonic for brain abscess
24.Which imaging pattern supports idiopathic normal pressure hydrocephalus?
DESH combines ventriculomegaly, enlarged Sylvian fissures and narrowed high-convexity or midline subarachnoid spaces. This uneven distribution of CSF spaces supports idiopathic normal pressure hydrocephalus in the appropriate clinical setting and differs from proportionate sulcal enlargement due to atrophy. The Japanese guideline describes high positive but low negative predictive value for DESH. Its absence therefore cannot independently exclude iNPH or settle whether further CSF-response assessment is worthwhile.
Apply it
An older adult with short-stepped gait and urinary urgency has enlarged ventricles and Sylvian fissures but tight high-convexity sulci. Recognise DESH and combine it with the clinical assessment rather than labelling every enlarged CSF space as generalised atrophy.
Common pitfall: Ventriculomegaly alone does not diagnose iNPH. Equally, absence of the complete DESH pattern is insufficient to rule it out when the clinical syndrome remains convincing.
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition · Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition — Journal PDF
25.Why obtain early MRI after glioma resection?
Early postoperative MRI establishes residual tumour burden and identifies complications before later postoperative changes complicate interpretation. EANO recommends assessment within 24–48 hours using imaging without and with contrast, including diffusion-weighted sequences to detect perioperative ischaemia. Contrast enhancement and diffusion answer different questions: one helps assess enhancing residual tissue, while the other can reveal acute injury. Subsequent response assessment needs this baseline rather than an unsupported assumption of complete resection.
Apply it
A patient develops new weakness after glioma surgery. Obtain early postoperative imaging that assesses both the resection cavity and diffusion abnormalities; a small residual enhancing focus would not alone explain an acute deficit caused by perioperative ischaemia.
Common pitfall: A contrast-only postoperative study can miss an important explanation for new neurological dysfunction. Delaying baseline imaging also makes later enhancement harder to classify reliably.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
26.How can advanced imaging improve glioma biopsy targeting?
Gliomas can be heterogeneous, so a biopsy from a less active region may underestimate the biologically important component. EANO describes perfusion MRI and amino acid PET as potentially useful for identifying metabolically active targets, particularly when biopsy rather than resection is planned. These techniques complement structural imaging and operative safety constraints. They guide where tissue may be informative, but they do not replace histological and molecular diagnosis or guarantee representative sampling.
Apply it
A deep heterogeneous lesion is suitable for stereotactic biopsy but not extensive resection. Review structural imaging alongside available perfusion or metabolic information to select an informative target while preserving a safe trajectory through surrounding structures.
Common pitfall: The brightest contrast-enhancing region is not automatically the safest or most informative target. Imaging activity must be reconciled with trajectory risk and adequate tissue acquisition.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
27.How does target size influence stereotactic radiation fractionation?
Radiation planning balances local tumour control against injury to normal tissue. In its discussion of recurrent glioma, EANO notes that larger lesions require smaller individual fractions to improve safety and tolerability. Stereotactic precision does not remove volume-related toxicity or uncertainty about re-irradiation benefit. Prior radiation, target size, surrounding structures and the clinical objective therefore influence whether a fractionated approach is suitable, rather than assuming every focal lesion merits single-fraction radiosurgery.
Apply it
A patient with previously irradiated glioma has a relatively large local recurrence. Discuss fractionation and cumulative normal-tissue exposure within multidisciplinary planning rather than selecting a single large fraction solely because the recurrence is geographically focal.
Common pitfall: Technical ability to focus radiation is not proof of a favourable therapeutic ratio. Re-irradiation efficacy and tolerability require separate assessment, especially for larger targets.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Neuro-oncology15% in the identified undated published Part I allocation; not a confirmed October 2026 weight
28.What makes a diffuse glioma diagnosis integrated?
An integrated glioma diagnosis combines morphology with molecular findings that define clinically distinct tumour groups. IDH status and, in appropriate IDH-mutant tumours, whole-arm 1p/19q codeletion distinguish major adult diffuse glioma entities. Histological resemblance alone can be misleading because similar-looking tumours can have different biology and treatment evidence. The supplied EANO guideline reflects its published classification framework; its central principle is that tissue interpretation and relevant molecular testing must be considered together.
Apply it
Two adult diffuse gliomas look oligodendroglial on initial microscopy, but only one has IDH mutation with whole-arm 1p/19q codeletion. Do not assign both the same integrated entity solely from cellular appearance; review their molecular results.
Common pitfall: A descriptive histological label does not necessarily establish the final disease entity. Conversely, an isolated molecular result must still be interpreted within the tissue and clinical context.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
29.When does negative IDH1 R132H staining require further testing?
IDH1 R132H immunohistochemistry detects the common mutation, rather than every possible IDH alteration. A negative stain therefore does not universally establish IDH-wild-type disease. EANO recommends sequencing relevant IDH1 and IDH2 regions in specified settings, including lower-grade diffuse gliomas and younger patients with glioblastoma-like histology. The discriminating issue is the assay’s coverage: a negative result for one variant differs from a comprehensive negative result for the gene family.
Apply it
A 34-year-old has a diffuse glioma with negative IDH1 R132H immunostaining. Request appropriate additional molecular testing before concluding that the tumour is IDH-wild-type, because less common IDH1 or IDH2 variants remain possible.
Common pitfall: An immunostain’s name identifies its target. Treating a variant-specific negative result as comprehensive sequencing can misclassify a tumour and misdirect interpretation of treatment evidence.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
30.Which molecular combination establishes oligodendroglioma?
Oligodendroglioma requires an IDH mutation together with whole-arm 1p/19q codeletion. Either feature alone is insufficient. In IDH-mutant gliomas, ATRX loss supports astrocytic lineage, whereas retained ATRX can prompt testing for codeletion. The molecular combination matters because disease-specific treatment evidence should be applied to the corresponding integrated entity. Partial chromosomal losses should not be casually equated with the defining whole-arm codeletion pattern.
Apply it
An adult diffuse glioma is IDH-mutant and retains ATRX expression. Testing confirms whole-arm 1p and 19q codeletion. Use the combined findings to support oligodendroglioma rather than relying on the retained ATRX result by itself.
Common pitfall: Retained ATRX does not independently diagnose oligodendroglioma. The defining combination remains IDH mutation plus whole-arm 1p/19q codeletion, interpreted with the pathological assessment.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
31.Why does MGMT promoter methylation matter for temozolomide?
MGMT repairs O6-methylguanine DNA lesions, counteracting an important effect of alkylating treatment. Promoter methylation is associated with reduced MGMT expression and greater expected benefit from temozolomide in glioblastoma. It is a treatment-response biomarker rather than a defining marker of oligodendroglial lineage. Its clinical influence depends on the treatment setting and patient factors; it should inform a treatment discussion without being presented as a guarantee of response.
Apply it
An older adult with glioblastoma is considering treatment options after biopsy. Explain how MGMT promoter methylation changes the expected value of alkylating chemotherapy, while also considering performance status and tolerability rather than making the biomarker the sole decision.
Common pitfall: Methylation does not guarantee tumour control, and an unmethylated result does not answer every treatment question. Avoid turning a probabilistic biomarker into an absolute prognosis.
MGMT gene silencing and benefit from temozolomide in glioblastoma · EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
32.How should neurological function constrain glioma resection?
Glioma surgery aims to remove useful amounts of tumour while preserving neurological function. EANO gives prevention of new permanent deficits higher priority than extent of resection because deficits can reduce independence, impair quality of life and delay further treatment. Infiltrative tumour may extend beyond a safe functional boundary. Operative adjuncts help define that boundary, but none converts a functionally critical region into tissue that can be removed without consequence.
Apply it
During resection near a language pathway, reliable testing deteriorates as the surgeon approaches residual tumour. Preserve the functional boundary rather than pursuing a radiological target whose removal would create a substantial permanent communication deficit.
Common pitfall: An association between greater resection and survival does not justify every additional cut. Functional harm can compromise both daily life and delivery of subsequent therapy.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
33.Why must language-mapping tasks be reliable before stimulation?
Language mapping depends on recognising a change from the patient’s baseline performance. An object that cannot be named reliably before stimulation cannot provide a clean test of stimulation-induced disruption. The supplied awake-surgery cohort used only objects named fluently during baseline assessment. Task selection therefore controls an important source of false localisation: difficulty caused by the task itself must be distinguished from reproducible disruption caused by stimulation at a particular site.
Apply it
Before awake mapping, a patient repeatedly hesitates over several unfamiliar pictures. Exclude those pictures from the operative task set and retain reliably named items so that subsequent naming failures can be interpreted against a stable baseline.
Common pitfall: Using a larger but unreliable picture set may create more apparent errors without improving mapping. Baseline task failure is not evidence of a positive stimulation site.
34.How can afterdischarges confound cortical stimulation mapping?
Electrical stimulation can trigger afterdischarges that extend beyond the intended local perturbation. A language error occurring during that activity may not identify a discrete essential language site. The supplied cohort recorded direct cortical EEG to detect afterdischarges during mapping. Reliable interpretation therefore combines behavioural performance, stimulation timing and electrophysiological information. A transient stimulation-related event must also be distinguished from worsening language during ongoing resection, which requires immediate reassessment of the operative boundary.
Apply it
A naming failure follows stimulation, while cortical EEG shows spreading afterdischarges. Pause and resolve the electrophysiological confound before labelling the stimulated point an essential language site; repeat assessment under interpretable conditions rather than extending the map from that event.
Common pitfall: Every stimulation-associated error is not a clean localisation result. Ignoring afterdischarges can overestimate a functional boundary or obscure the cause of the behavioural change.
35.What can 5-ALA fluorescence establish during glioma surgery?
5-ALA facilitates intraoperative visualisation of malignant glioma-associated fluorescence, but its prescribing information warns of false-negative and false-positive findings. Nonfluorescent tissue can still contain tumour, and fluorescence can occur with inflammation or other tumour types. Fluorescence is therefore an adjunct to surgical judgement, pathology and functional assessment. It neither proves a histological diagnosis nor establishes a safe functional boundary, and absence of fluorescence cannot certify complete microscopic tumour removal.
Apply it
Residual tissue near a mapped motor pathway fluoresces during glioma resection. Integrate that finding with the functional boundary rather than treating fluorescence as permission to continue. Conversely, a nonfluorescent cavity margin cannot establish that infiltrating tumour is absent.
Common pitfall: Equating fluorescence with a compulsory resection target confuses tumour visualisation with functional safety. Both false positives and false negatives limit the conclusions that fluorescence supports.
36.How should early enhancement after chemoradiotherapy be interpreted?
Increased enhancement after glioma chemoradiotherapy can reflect treatment-related change rather than active tumour growth. Enhancement measures blood–brain barrier disturbance and is not a direct count of viable tumour cells. EANO discusses pseudoprogression and the use of clinical assessment, serial imaging and selected advanced imaging to clarify uncertain findings. A clinically stable patient with an equivocal early scan may therefore need confirmation before an effective treatment is abandoned or recurrence is declared.
Apply it
A patient remains neurologically stable but develops increased enhancement within the treated region shortly after chemoradiotherapy. Review the timing and baseline studies, consider pseudoprogression and arrange a justified reassessment strategy instead of automatically changing treatment.
Common pitfall: Early timing does not prove pseudoprogression either. Clinical deterioration or convincing progression still needs active evaluation; the principle is to resolve uncertainty using the full context.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Neurovascular10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
37.Why should a ruptured aneurysm be secured early?
An unsecured ruptured aneurysm remains a source of potentially devastating rebleeding. The AHA/ASA guideline summary recommends prompt identification and treatment, preferably within 24 hours, with complete obliteration whenever feasible to reduce rebleeding and retreatment. Selecting clipping or endovascular treatment requires assessment of aneurysm and patient characteristics by appropriately experienced clinicians. Physiological stabilisation and management of associated complications accompany aneurysm treatment rather than replacing protection against recurrent haemorrhage.
Apply it
An adult with aneurysmal subarachnoid haemorrhage is initially alert after resuscitation. Arrange prompt specialist evaluation for aneurysm occlusion; apparent neurological stability does not remove the ongoing hazard posed by the unsecured rupture site.
Common pitfall: Waiting for vasospasm risk to pass leaves the rupture source untreated. Early stability and later ischaemic complications address different parts of the disease course.
AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
38.What benefit does nimodipine provide after aneurysmal subarachnoid haemorrhage?
Early enteral nimodipine is beneficial for preventing delayed cerebral ischaemia and improving functional outcomes after aneurysmal subarachnoid haemorrhage. Its clinical role should be expressed through those outcomes rather than assuming it mechanically eliminates all angiographic vasospasm. The AHA/ASA summary does not recommend routine statin treatment or intravenous magnesium for this purpose. Distinguishing proven clinical benefit from an appealing vascular or biochemical rationale helps select appropriate preventive therapy.
Apply it
After aneurysm treatment, an adult has no current focal deficit. Explain that nimodipine addresses subsequent ischaemic risk and functional outcome; it is not reserved only for patients who already show a narrowed artery on vascular imaging.
Common pitfall: A normal current examination does not remove the indication for preventive treatment. Conversely, nimodipine does not replace investigation of a new neurological deficit.
AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
39.Why is euvolaemia preferred to prophylactic hypervolaemia after subarachnoid haemorrhage?
Maintaining euvolaemia supports cerebral perfusion without intentionally exposing the patient to excess fluid. The AHA/ASA guideline summary advises against prophylactic hypervolaemia and haemodynamic augmentation because of iatrogenic risk. This differs from directed treatment of symptomatic delayed cerebral ischaemia, where blood-pressure elevation can be beneficial in selected patients. The presence or absence of an active ischaemic complication therefore changes the rationale for haemodynamic intervention; preventive fluid loading is not equivalent to targeted rescue treatment.
Apply it
A stable adult after aneurysm occlusion has no delayed neurological deficit. Continue assessment aimed at euvolaemia rather than prescribing deliberate fluid excess and hypertension solely because the patient has entered the period associated with delayed cerebral ischaemia.
Common pitfall: The older habit of applying every component of haemodynamic augmentation prophylactically overlooks treatment-related harm. A risk period alone does not establish symptomatic ischaemia.
AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
40.How should a new deficit during the delayed ischaemia period be assessed?
A new focal deficit or reduced consciousness after subarachnoid haemorrhage requires rapid assessment rather than automatic attribution to vasospasm. Clinical examination, vascular imaging and perfusion assessment can help evaluate delayed cerebral ischaemia, while structural and physiological alternatives also need consideration. The AHA/ASA summary identifies transcranial Doppler, CT angiography and CT perfusion as useful modalities in expert hands. Patients with limited examinations may require additional monitoring to detect clinically important deterioration.
Apply it
Several days after aneurysm treatment, a patient becomes less responsive. Reassess the neurological examination and systemic state, obtain appropriate imaging for hydrocephalus or haemorrhage, and evaluate vascular or perfusion abnormalities before assuming that one mechanism explains the decline.
Common pitfall: Angiographic narrowing and clinical delayed cerebral ischaemia are related but different findings. A vascular image alone does not explain every deterioration or exclude competing complications.
AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
41.How is the Spetzler–Martin grade constructed and used?
Add three components. Maximum AVM nidus diameter below 3 cm contributes one point, 3–6 cm contributes two points, and above 6 cm contributes three points. Noneloquent location contributes zero points; eloquent location contributes one point. Superficial-only venous drainage contributes zero points; any deep venous drainage contributes one point. The sum gives grade I–V. Eloquent structures include sensorimotor, language and visual cortex, the thalamus, internal capsule and brainstem. The scale estimates microsurgical treatment risk; it does not calculate annual rupture probability or independently determine treatment.
Apply it
A 4 cm nidus in eloquent brain with both superficial and deep venous drainage scores two points for size, one for eloquence and one for any deep drainage: grade IV. A 2 cm noneloquent nidus with superficial-only drainage scores one point overall: grade I. Exactly 3 cm and exactly 6 cm both fall within the two-point size category.
Common pitfall: Measure the nidus rather than an enlarged draining vein. Mixed superficial and deep drainage still receives the deep-drainage point. Deep location and deep venous drainage are separate descriptors: eloquence is assessed through the location component, whereas the drainage component concerns venous outflow. Use the completed grade to inform microsurgical risk assessment rather than treating it as a stand-alone treatment recommendation.
A proposed grading system for arteriovenous malformations · GetPdf.cgi
42.Why continue vascular imaging after aneurysm treatment?
Aneurysm treatment can leave a remnant, and treated aneurysms can recur or regrow. The AHA/ASA summary supports post-treatment and subsequent imaging to guide management of these findings and assess other known aneurysms. Surveillance for newly developing aneurysms is also relevant in selected higher-risk patients. A technically successful initial procedure therefore does not make vascular follow-up irrelevant; the purpose is to identify a lesion change that could alter future haemorrhage prevention.
Apply it
A patient has recovered well after aneurysm treatment but has a documented small residual component. Explain that follow-up vascular imaging addresses structural durability and future management, even though symptoms and the current neurological examination have improved.
Common pitfall: Clinical recovery cannot demonstrate complete aneurysm occlusion. Surveillance intervals and modality require individual planning rather than assuming a single universal schedule for every treated aneurysm.
AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
Spine10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
43.Which findings distinguish cervical myelopathy from isolated radiculopathy?
Cervical myelopathy reflects spinal cord dysfunction and can produce impaired hand dexterity, gait disturbance and long-tract signs below the compressed level. Radiculopathy primarily produces root-related pain, sensory change, weakness or reflex loss in a segmental pattern. They can coexist, so reduced reflexes at one level do not exclude cord disease elsewhere. Matching symptoms and examination to cervical imaging is essential because radiological compression alone does not establish symptomatic myelopathy.
Apply it
An adult reports hand clumsiness and progressive gait imbalance alongside arm pain. Brisk leg reflexes and cervical cord compression make isolated radiculopathy an incomplete explanation; assess the severity and progression of the associated myelopathy.
Common pitfall: Arm pain can distract from cord dysfunction. Conversely, an impressive MRI should not be used to label an asymptomatic patient myelopathic without corresponding clinical findings.
Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy · UTHealth Medical Neuroscience 2013 Laboratory Guide
44.How does functional severity guide surgery for degenerative cervical myelopathy?
The AOSpine/CSRS guideline classifies degenerative cervical myelopathy using the modified Japanese Orthopaedic Association score: mild 15–17, moderate 12–14 and severe 0–11. The 18-point scale assesses upper-limb motor function, lower-limb motor function, hand sensation and sphincter function; lower scores indicate greater impairment. Surgery is recommended for moderate or severe disease. Mild disease can be managed with surgery or supervised structured rehabilitation. During nonoperative care, neurological deterioration warrants surgery, while failure to improve supports offering surgery. Assess neurological function and progression alongside concordant imaging rather than grading severity from neck pain.
Apply it
A patient has slight difficulty buttoning a shirt, needs a handrail on stairs, has mild hand sensory loss and normal bladder function. Corresponding mJOA subscores of 4 + 4 + 2 + 3 give 13/18, indicating moderate disease. With concordant cervical cord compression, recommend surgical intervention.
Common pitfall: A decline from mJOA 17 to 15 remains within the mild category but represents deterioration. Do not wait for progression into the moderate category before recommending surgery when neurological function worsens during nonoperative management.
Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy · A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy · content
45.How can mild cervical myelopathy be managed initially?
For mild degenerative cervical myelopathy, the AOSpine/CSRS guideline suggests either surgery or a supervised trial of structured rehabilitation. If nonoperative management is chosen, neurological deterioration warrants operative intervention, and failure to improve supports reconsideration of surgery. Observation therefore requires an explicit reassessment plan and recognition of worsening hand function, gait or other cord symptoms. It is an active strategy with defined boundaries, rather than permission to ignore emerging neurological change.
Apply it
A patient with mild stable myelopathy chooses structured rehabilitation after counselling. At follow-up, walking and hand dexterity have worsened. This new deterioration changes the management balance and should trigger renewed surgical assessment rather than automatic continuation of the original plan.
Common pitfall: The option of rehabilitation applies to an appropriately assessed mild presentation. It does not justify persisting with the same strategy after documented neurological deterioration.
Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy · A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy
46.What changes management of nonmyelopathic cervical cord compression?
The AOSpine/CSRS guideline advises against prophylactic surgery for nonmyelopathic cord compression without radiculopathy, favouring education and clinical follow-up. Associated clinical radiculopathy identifies a group at greater risk of developing myelopathy. For that group, surgery or close serial follow-up with structured nonoperative management can be offered. The important distinction is therefore not simply compression present versus absent, but whether cord dysfunction or a higher-risk clinical pattern accompanies the imaging finding.
Apply it
An adult has incidental cervical cord compression, no myelopathic signs and no radicular symptoms. Explain warning symptoms and arrange clinical follow-up. A second patient with the same imaging plus radiculopathy needs a different discussion of progression risk and management options.
Common pitfall: Incidental compression is not automatically a surgical disease. However, counselling should not imply zero progression risk or omit the symptoms that should prompt reassessment.
Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy · A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy
47.When should suspected cauda equina syndrome prompt urgent MRI?
New bladder dysfunction, altered saddle sensation or other sacral neurological symptoms in a compatible presentation raise concern for cauda equina syndrome. WFNS recommends urgent MRI in suspected cases because clinical examination has insufficient sensitivity to exclude compression reliably. Preserved anal tone or a reassuring single bladder measurement cannot independently settle the diagnosis. Imaging tests for a surgically treatable compressive lesion while the clinical assessment defines onset, progression and the extent of neurological dysfunction.
Apply it
An adult with acute bilateral leg pain develops altered urinary sensation and saddle numbness but retains measurable anal tone. Arrange urgent MRI for suspected cauda equina compression rather than using that isolated examination finding to dismiss the presentation.
Common pitfall: Complete painless retention is a late pattern, not a prerequisite for urgent investigation. Waiting for every classic feature risks missing an earlier, potentially reversible compressive syndrome.
48.How should confirmed compressive cauda equina syndrome be prioritised?
MRI-confirmed cauda equina compression with a compatible neurological syndrome requires urgent surgical assessment and decompression planning. WFNS recommends decompression within 48 hours, preferably within 24 hours, while acknowledging limitations in the timing literature. These intervals are not permission to wait: earlier treatment is pursued when feasible. Documenting symptom onset and baseline bladder, saddle and motor function helps interpretation of urgency and outcome, but uncertainty about the exact onset should not create avoidable delay.
Apply it
MRI demonstrates a large compressive disc in a patient with evolving saddle sensory loss and urinary dysfunction. Activate urgent decompression planning immediately rather than scheduling surgery near the end of a nominal time window because the patient can still move both legs.
Common pitfall: A timing recommendation is not a safe waiting period. Preserved limb power does not negate clinically important sacral dysfunction or remove the need for urgent treatment.
Hydrocephalus/ CSF disorders/ Congenital10% in the identified undated published Part I allocation; not a confirmed October 2026 weight
49.How is ventricular index measured in neonatal posthaemorrhagic dilatation?
Ventricular index is measured from the midline falx to the lateral ventricular border on a coronal ultrasound view at the foramina of Monro. The Czech Neonatological Society guideline distinguishes this measurement from anterior horn width, which is a diagonal ventricular measurement in the same projection. Consistent landmarks and planes make serial measurements interpretable. Confusing different ventricular dimensions can create an apparent change that reflects measurement technique rather than true evolution of ventricular dilatation.
Apply it
A premature infant has serial ultrasound after intraventricular haemorrhage. One report measures falx-to-lateral-wall distance and another records a diagonal anterior horn dimension. Identify the different measurements before interpreting their numerical difference as rapid ventricular growth.
Common pitfall: Ventricular index and anterior horn width are not interchangeable names for the same distance. Serial comparisons require the same anatomical definition and imaging plane.
Czech Neonatological Society — Posthaemorrhagic Ventricular Dilatation
50.What determines permanent shunt timing after neonatal haemorrhage?
Assess serial ultrasound or MRI for persistent or progressive ventricular enlargement and whether ventricular control still requires temporary CSF drainage. The Czech guideline lists continuing reservoir drainage after at least 28 days of intermittent taps as a practical criterion for considering a ventriculoperitoneal shunt. Assess hydrocephalus severity, the infant's general condition, associated complications and infection, using clinical findings and CSF biochemical, cytological and culture results. It also recommends CSF protein below approximately 1.5–2 g/L, while explicitly acknowledging insufficient evidence for a specific weight or CSF parameter to dictate timing. These practical recommendations are not universally validated readiness thresholds.
Apply it
After a month of reservoir taps, a premature infant's ventricles repeatedly enlarge when drainage is reduced. Persistent drainage dependence and progressive imaging findings support considering permanent diversion. Review medical stability, associated complications and infection investigations before proceeding; reaching a target weight alone does not establish readiness.
Common pitfall: Do not mistake the absence of universal thresholds for absence of concrete criteria. Conversely, neither 28 days of drainage nor a particular protein concentration independently mandates shunting.
Czech Neonatological Society — Posthaemorrhagic Ventricular Dilatation
51.Which clinical pattern makes iNPH worth investigating?
Idiopathic normal pressure hydrocephalus is considered when an older adult develops a compatible gait disorder, cognitive impairment or urinary dysfunction alongside ventriculomegaly. Gait is often particularly informative, but the complete triad need not be equally developed. Evaluation must also identify comorbid neurological and musculoskeletal disease that could explain symptoms or limit treatment benefit. The diagnosis therefore joins clinical findings and imaging rather than treating either ventricular size or a nonspecific symptom as sufficient.
Apply it
An older adult has progressive short-stepped gait, urinary urgency and ventricular enlargement. Assess cognition, gait objectively and competing explanations such as degenerative or musculoskeletal disease before deciding whether CSF-response testing will meaningfully clarify potential shunt benefit.
Common pitfall: The triad is a clinical framework, not proof that every symptom has one cause. Coexisting disease can alter both diagnosis and the benefit expected from diversion.
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition
52.How should a positive or negative CSF tap test affect shunt assessment?
Improvement after CSF removal supports iNPH and predicts potential benefit from shunting. A negative tap test has a different meaning: false negatives occur, so lack of observed improvement does not exclude iNPH or shunt responsiveness. The Japanese guideline emphasises interpretation alongside symptoms, imaging and assessment quality. The test should therefore update the probability of benefit rather than act as an infallible binary gate separating every suitable patient from every unsuitable one.
Apply it
An older adult has a characteristic gait disorder and DESH but no improvement on one tap test. Review when and how gait was measured and reassess the combined evidence; do not automatically remove the patient from further shunt evaluation.
Common pitfall: The evidential value of a positive response and a negative response is not symmetrical. A single negative result cannot erase a convincing clinical and imaging pattern.
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition · Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition — Journal PDF
53.Why does tap-test assessment timing matter?
A CSF tap test is only interpretable if the relevant functions are assessed before and after drainage using suitable methods. The Japanese guideline recommends evaluation within 24 hours and repeated assessments for up to a week because improvement can be delayed and different symptoms may change at different times. Objective gait measures improve comparison. An immediate subjective impression alone can therefore miss a clinically relevant response and falsely suggest that CSF removal had no effect.
Apply it
A patient is labelled a tap-test nonresponder after a brief bedside review immediately after lumbar puncture. Compare standardised pretest gait data with later assessments, including the next day, before accepting that the test demonstrated no meaningful change.
Common pitfall: Removing CSF completes the procedure but not the assessment. Without a baseline and appropriately timed follow-up, an apparent negative result may reflect the measurement process.
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition — Journal PDF
54.How does aqueduct obstruction shape ventricular enlargement?
CSF normally passes from the lateral ventricles through the foramina of Monro into the third ventricle, then through the aqueduct into the fourth ventricle. Aqueduct obstruction therefore enlarges the upstream lateral and third ventricles while the fourth ventricle may remain relatively normal in size. This anatomical pattern can occur with congenital narrowing or acquired obstruction. Identifying the blocked level helps distinguish an obstructive process from more diffuse impairment of CSF circulation.
Apply it
A child with progressive symptoms has enlarged lateral and third ventricles but a relatively normal fourth ventricle. Examine the aqueduct and adjacent structures for an obstructive cause rather than assuming that every ventricular compartment must enlarge equally.
Common pitfall: Ventricular size patterns localise a possible obstruction but do not establish its cause or automatically determine the best diversion procedure. Review the actual CSF pathways.
Neurology2% in the identified undated published Part I allocation; not a confirmed October 2026 weight
55.Why must medication confounders be excluded before neurological-death assessment?
Sedatives and other CNS-depressing drugs can suppress consciousness and brainstem responses, creating findings that cannot be attributed confidently to permanent brain injury until drug effects are excluded. The 2023 consensus guideline requires assessment of relevant medications, levels where available and clearance factors. Renal or hepatic dysfunction, hypothermia and prolonged exposure can delay elimination. The guideline is a clinical reference; the legally applicable neurological-death process must also follow the jurisdiction’s requirements.
Apply it
A deeply comatose adult has absent brainstem reflexes after prolonged sedation and acute renal failure. Establish whether drug effects have cleared before proceeding with a formal neurological-death assessment; stopping an infusion does not immediately establish freedom from confounding.
Common pitfall: A routine clearance interval may be unreliable when elimination is impaired. Profound examination abnormalities cannot override an unresolved pharmacological explanation for those findings.
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline
Infection2% in the identified undated published Part I allocation; not a confirmed October 2026 weight
56.Why does confirmed CSF shunt infection require source control?
Infected shunt hardware can sustain infection despite antimicrobial exposure, so management must address the device as well as the organism. IDSA recommends complete removal of an infected CSF shunt, replacement with an external ventricular drain and intravenous antimicrobial therapy. CSF culture is central to diagnosis and guides treatment with clinical assessment. Cell count, glucose and protein alone are insufficiently reliable to establish or exclude healthcare-associated infection, especially after neurosurgery or haemorrhage.
Apply it
A shunt-dependent patient has fever, shunt-tract tenderness and repeated positive CSF cultures consistent with infection. Plan hardware source control, temporary external CSF drainage and organism-directed treatment rather than expecting antibiotics alone to sterilise the retained shunt reliably.
Common pitfall: A near-normal CSF cell count does not exclude device infection. Conversely, postoperative inflammatory CSF changes alone should not substitute for careful microbiological and clinical interpretation.
IDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
Functional/ epilepsy2% in the identified undated published Part I allocation; not a confirmed October 2026 weight
57.When should drug-resistant epilepsy prompt surgical evaluation?
Drug resistance is established after failure of adequate trials of two tolerated, appropriately chosen antiseizure medication schedules to achieve sustained seizure freedom. ILAE consensus supports timely referral for comprehensive surgical evaluation once drug resistance is recognised. Referral clarifies diagnosis, localisation, functional risk and treatment options; it does not commit the patient to resection. Evaluation can identify unsuitable resections, alternative interventions or improved medical management, so uncertainty about candidacy should not automatically postpone referral.
Apply it
A child continues to have disabling seizures despite two appropriate, tolerated medication schedules used adequately. Refer for comprehensive epilepsy-surgery evaluation while ongoing care continues; do not require years of additional medication failures before assessing potentially effective interventions.
Common pitfall: Two prescriptions alone do not establish drug resistance if choice, tolerance or adequacy was poor. Once genuine resistance exists, referral and selection of surgery remain separate decisions.
ILAE Expert Consensus Recommendations on Timing of Referral to Evaluate for Epilepsy Surgery · Timing of referral to evaluate for epilepsy surgery — ILAE Surgical Therapies Commission report
Peripheral nerve2% in the identified undated published Part I allocation; not a confirmed October 2026 weight
58.How should carpal tunnel injection and release be compared?
The AAOS 2024 guideline finds that corticosteroid injection can provide short-term symptom relief but does not provide long-term improvement in carpal tunnel syndrome. It also finds similar long-term outcomes for mini-open and endoscopic release. Counselling should distinguish temporary relief from the objectives of decompression and compare approaches using patient circumstances, risks and expertise. An intervention’s convenience or incision size does not by itself establish superior durable neurological or functional benefit.
Apply it
An adult’s nocturnal hand symptoms recur after temporary benefit from injection. Explain the expected limits of repeating a symptom-relief strategy and discuss decompression when clinically appropriate, without claiming that endoscopic release universally produces better long-term outcomes than mini-open release.
Common pitfall: Short-term improvement is not evidence of durable treatment success. Likewise, similar long-term outcomes do not mean every procedural risk or recovery experience is identical.
AAOS Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline
Miscellaneous including statistics and ethics2% in the identified undated published Part I allocation; not a confirmed October 2026 weight
59.How do sensitivity, specificity and predictive value use different denominators?
Sensitivity is the proportion of patients with the target condition who test positive; specificity is the proportion without it who test negative. Positive predictive value instead asks what proportion of positive results represent true disease. Its denominator is all positive tests, making it sensitive to disease prevalence in the tested population. FDA guidance also distinguishes accuracy against an appropriate reference standard from agreement with a comparator that does not establish true disease status.
Apply it
A study finds 36 positive tests among 40 patients with disease and 18 positive tests among 180 without disease. Sensitivity is 36/40, or 90%; positive predictive value is 36/54, about 67%, because false positives enter that denominator.
Common pitfall: High sensitivity is not the probability that a positive patient has disease. That reverses the conditional question and ignores false positives and the population being tested.
FDA Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests
60.How should shared decisions address a potentially acceptable neurological deficit?
Shared decision-making requires explaining the expected benefit, meaningful alternatives and the functional consequences that matter to the particular patient. EANO notes that an anticipated limited deficit may occasionally be acceptable after a thorough discussion, while prevention of permanent neurological harm remains central. The surgeon should connect a proposed deficit to daily activities and uncertainty, rather than assuming a technically small deficit is personally minor. The patient’s informed priorities help define an acceptable treatment trade-off.
Apply it
A proposed glioma resection could improve tumour removal but create a visual-field deficit. Discuss effects on driving, work and independence alongside alternatives and uncertainty; a patient whose occupation depends on intact fields may value the trade-off differently.
Common pitfall: Consent to an operation does not automatically establish acceptance of every foreseeable functional loss. The meaning of a deficit depends on the patient’s life and goals.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Localise before naming disease: connect visual fields, cranial nerves, long tracts and ventricular patterns to precise anatomy.
- Recognise time-critical decisions in traumatic haematomas, posterior fossa compression, aneurysmal haemorrhage and cauda equina syndrome.
- Calculate CPP correctly and distinguish an improved physiological measurement from improved neurological outcome.
- Integrate glioma histology, molecular markers, functional boundaries and postoperative imaging without overstating any single adjunct.
- Practise adult and paediatric CSF decisions, including measurement definitions, test limitations and uncertainty around neonatal shunt timing.
- Explain why each alternative is less appropriate, then rehearse the investigation, treatment, complications and shared decision aloud.
- Use the full official scope to extend study beyond these concepts, especially biomechanics, spinal trauma, radiotherapy, congenital disease, movement disorders and pain.
A practical preparation plan
1. Build an anatomical explanation
For each neurological deficit, state the side, level, tract or structure and expected associated findings. Draw visual pathways and ventricular connections from memory, then check the prediction against an unfamiliar case.
2. Create emergency decision pairs
Contrast a lesion meeting an operative criterion with one suitable for monitored observation. Change one feature at a time—thickness, shift, GCS, focal deficit or neurological trajectory—and explain how the decision changes.
3. Link investigations to decisions
For DWI, ADC, molecular testing, CSF cultures and tap testing, identify the question answered, the important false inference and the next decision. Include at least one plausible discordant result in each revision session.
4. Work through the independent drills
Answer all 20 questions before reviewing explanations. Record errors by mechanism: localisation, threshold, assay limitation, indication or evidence interpretation. Correct the reasoning and then use the related flashcard after a delay.
5. Rehearse oral clinical reasoning
Present a brain case, a spine case and a mixed case aloud. Move from differential diagnosis to investigations, treatment selection, operative hazards, postoperative care and the patient’s priorities; practise responding to a new complication.
6. Audit breadth against the official scope
Map remaining weaknesses to the official Basic Science and Cranial and Spinal Neurosurgery headings. Preserve paediatric revision across domains and add topics absent from this selective guide before considering preparation complete.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Fellow of the European Board of Neurological Surgery — Examination and Scope
- Fellowship of the European Board of Neurological Surgeons: Part 1 Exam
- EANS Annual Report 2024–2025
- UEMS European examinations
- Fellow of the European Board of Neurological Surgery — Older Handbook
- UTHealth Medical Neuroscience 2013 Laboratory Guide
- Neurosurgical anatomy of the floor of the third ventricle and related vascular structures
- Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
- Brain Trauma Foundation — Severe TBI, Fourth Edition Recommendations
- Brain Trauma Foundation — Surgical Management of TBI
- Restricted diffusion within ring enhancement is not pathognomonic for brain abscess
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- MGMT gene silencing and benefit from temozolomide in glioblastoma
- DailyMed — Gleolan Prescribing Information
- AHA/ASA — Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
- A proposed grading system for arteriovenous malformations
- Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy
- Cauda equina, conus medullaris and syndromes mimicking sciatic pain: WFNS spine committee recommendations
- Czech Neonatological Society — Posthaemorrhagic Ventricular Dilatation
- Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition
- Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline
- IDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis
- ILAE Expert Consensus Recommendations on Timing of Referral to Evaluate for Epilepsy Surgery
- AAOS Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline
- FDA Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests
- Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition — Journal PDF
- Timing of referral to evaluate for epilepsy surgery — ILAE Surgical Therapies Commission report
- A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy
- Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus, Third Edition — Published Journal Page
- European training requirements in neurological surgery: A new outcomes-based 3 stage UEMS curriculum
- Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study
- Client Challenge
- content
- GetPdf.cgi
- Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM - PMC
- No Routine Postoperative Head CT following Elective Craniotomy – A Paradigm Shift? | PLOS One
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.